prednisolone (Q11426176)

prednisolone (English)

17 November 2016

chemical formula

C₂₁H₂₈O₅

1 reference

prednisolone (English)

17 November 2016

canonical SMILES

CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O

1 reference

prednisolone (English)

17 November 2016

isomeric SMILES

C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)CCC4=CC(=O)C=C[C@]34C)O

1 reference

prednisolone (English)

17 November 2016

defined daily dose

10 milligram

oral administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=H02AB06

10 milligram

parenteral route of administration

1 reference

https://www.whocc.no/atc_ddd_index/?code=H02AB06

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

15 February 2018

World Health Organisation international non-proprietary name

prednisolone (English)

2 references

prednisolone (English)

3 October 2016

published in

Recommended INN: List 3

publication date

1959

MedlinePlus drug identifier

mental depression

1 reference

a615042

quotation

Some side effects can be serious. / ... / depression (English)

medical condition treated

1 reference

13 December 2016

1 reference

functional gastrointestinal disorder

13 December 2016

1 reference

hematopoietic system disease

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

acute graft versus host disease

13 December 2016

1 reference

granulomatosis with polyangiitis

2 October 2018

1 reference

2 October 2018

nephrotic syndrome

1 reference

2 October 2018

acquired hemophilia

1 reference

2 October 2018

polymyositis

1 reference

drug reaction with eosinophilia and systemic symptoms

2 October 2018

1 reference

2 October 2018

lymphoma

1 reference

diffuse large B-cell lymphoma

2 October 2018

1 reference

interstitial lung disease

2 October 2018

1 reference

graft-versus-host disease

2 October 2018

1 reference

2 October 2018

ulcerative colitis

1 reference

2 October 2018

polymyalgia rheumatica

1 reference

2 October 2018

non-Hodgkin lymphoma

1 reference

2 October 2018

uveitis

1 reference

2 October 2018

pyoderma gangrenosum

1 reference

2 October 2018

myasthenia gravis

1 reference

2 October 2018

B-cell lymphoma

1 reference

2 October 2018

autoimmune hepatitis

1 reference

membranous glomerulonephritis

2 October 2018

1 reference

2 October 2018

giant cell arteritis

1 reference

systemic-onset juvenile idiopathic arthritis

2 October 2018

1 reference

2 October 2018

bullous pemphigoid

1 reference

autoimmune hemolytic anemia

2 October 2018

1 reference

2 October 2018

eye inflammation

1 reference

significant drug interaction

2 October 2018

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

Achor-Smith syndrom

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

Achor-Smith syndrom

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nabumetone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

naproxen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

celecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Diclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

piroxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

meloxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-fenoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(+-)-flurbiprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ibuprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

indomethacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-ketoprofen

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-etodolac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sulindac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

parecoxib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aceclofenac

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tenoxicam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Decreased circulating cortisol level

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Cushing's syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

tendon rupture

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Nuclear receptor subfamily 3 group C member 1

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Nuclear receptor subfamily 3 group C member 2

17 August 2016

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

17 August 2016

Glucocorticoid receptor

subject has role

agonist

1 reference

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL131

pregnancy category

Australian pregnancy category A

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

5-lipoxygenase inhibitor

1 reference

5 March 2018

selective glucocorticoid receptor agonist

1 reference

5 March 2018

anti-inflammatory agent

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

MeSH descriptor ID

D011239

hormonal antineoplastic agent

15 March 2018

1 reference

Food and Drug Administration

Medical Subject Headings

15 March 2018

0 references

prednisoLONE

subject named as

Prednisolone

1 reference

https://www.fda.gov/drugs/medication-errors-related-cder-regulated-drug-products/fda-name-differentiation-project

2 September 2022

0 references

0 references

0 references

1 reference

imported from Wikimedia project

English Wikipedia

Commons category

Prednisolone

0 references

Identifiers

InChI

InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

1 reference

prednisolone (English)

17 November 2016

2 references

prednisolone (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

50-24-8

2 references

prednisolone (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=50-24-8

10 April 2021

1 reference

prednisolone (English)

17 November 2016

2 references

prednisolone (English)

17 November 2016

Reaxys registry number

1354103

1 reference

prednisolone (English)

3 October 2016

ChEBI ID

8378

mapping relation type

2 references

PREDNISOLONE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1

1 reference

PREDNISOLONE (English)

17 November 2016

2 references

inferred from InChIKey

MSBNK-Fac_Eng_Univ_Tokyo-JP010057

1 reference

MassBank accession ID

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Athens_Univ-AU239857

0 references

MSBNK-Athens_Univ-AU239858

0 references

MSBNK-Athens_Univ-AU239859

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA002337

0 references

MSBNK-Waters-WA002338

0 references

MSBNK-Waters-WA002339

0 references

MSBNK-Waters-WA002340

0 references

MSBNK-Waters-WA002341

0 references

SPLASH

splash10-002f-0009000000-4a00ac3c2f4930e108cc

0 references

splash10-0005-0689000000-b0eaba9949ae34d0e571

0 references

splash10-00dj-0900000000-0a92fbafb31c0170151c

0 references

splash10-00dj-0900000000-856481c7f4d3a6d1ac63

0 references

splash10-00dj-0900000000-813955b7791f046a3a67

0 references

splash10-00di-0900000000-c70a1009bba6e4f3a2c8

0 references

splash10-0006-0009000000-e4bce0d078573494d8cd

0 references

splash10-006w-0905000000-94eb00e6ffa4c56ac51b

0 references

splash10-00dj-0900000000-7797dc6be351391cf57a

0 references

splash10-00dj-0900000000-d156992d517e46c9575d

0 references

splash10-00r2-0910000000-598b90f7f0f7ba4e13eb

0 references

splash10-00di-0900000000-eed30fed077e1dfffd3b

0 references

splash10-002f-0009000000-0af4f657def15fe9274e

0 references

splash10-00di-1910000000-2f59b266e7257ff0e7ad

0 references

splash10-03di-1920000000-5811b59a6f57222762d7

0 references

splash10-06xw-2910000000-84fec77617e1b7a1648b

0 references

splash10-03dl-0596000000-e0abadaf09054d046b08

0 references

splash10-03xu-0595000000-4f8d30df506ea649fc04

0 references

splash10-006x-1986000000-d088900fa4c56b9ff51d

0 references

splash10-0159-0900000000-01f9c0e6f14839685506

0 references

HSDB ID

3385

1 reference

Hazardous Substances Data Bank

28 October 2019

PREDNISOLONE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

0 references

1 reference

prednisolone (English)

ECHA Substance Infocard ID

17 November 2016

100.000.020

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.000.020

27 December 2018

Prednisolone (English)

quotation

CAS no.: 50-24-8 (English)

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

Prednisolone (English)

17 November 2015

1 reference

World Health Organisation international non-proprietary name numeric ID

Prednisolone (English)

publication date

17 November 2015

535

1 reference

https://mednet-communities.net/inn/db/ViewINN.aspx?i=535

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

D04.210.500.745.432.769.795

prednisolone (English)

17 November 2016

Prednisolone

0 references

MeSH concept ID

M0017460

0 references

MeSH tree code

0 references

RxNorm ID

8638

1 reference

prednisolone (English)

17 November 2016

DrugBank ID

DB00860

1 reference

Human Metabolome Database ID

HMDB0014998

2 references

based on heuristic

inferred from InChIKey

2 references

prednisolone (English)

17 November 2016

MedlinePlus drug identifier

a615042

oral administration

0 references

a682794

0 references

1 reference

prednisolone (English)

17 November 2016

0 references

1 reference

1 reference

prednisolone (English)

3 October 2016

1 reference

http://www.lipidmaps.org/rest/compound/lm_id/LM/all/download

prednisolone (English)

3 October 2016

1 reference

30 June 2018

0 references

prednisolóne

0 references

DeCS ID

22620

0 references

electronic Essential Medicines List medicine ID

0 references

Freebase ID

/m/02yzx9

0 references

Gran Enciclopèdia Catalana ID

prednisolona

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0134133

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

archive URL

https://web.archive.org/web/20220125070108/https://docs.openalex.org/download-snapshot/snapshot-data-format

25 January 2022

1 reference

prednisolone (English)

17 November 2016

WikiProjectMed ID

Prednisolone

0 references

WordNet 3.1 Synset ID

14777367-n

1 reference